Pharming Group N.V. (AMS:PHARM)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
0.9938
-0.0342 (-3.33%)
Aug 14, 2026, 5:38 PM CET

Pharming Group Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
703977627690707503
Market Cap Growth
6.72%55.71%-9.08%-2.41%40.66%-38.05%
Enterprise Value
664947587658657487
Last Close Price
0.991.430.931.031.080.78
PE Ratio
89.72402.37--55.2735.75
Forward PE
62.2060.6960.69170.0928.9616.47
PS Ratio
2.193.052.193.113.682.88
PB Ratio
2.974.142.943.493.692.96
P/TBV Ratio
5.648.104.065.175.825.23
P/FCF Ratio
23.3821.26--35.8521.10
P/OCF Ratio
22.9420.97--33.6615.11
EV/Sales Ratio
2.072.962.052.973.412.78
EV/EBITDA Ratio
20.4228.07188.69-40.9718.22
EV/EBIT Ratio
29.0333.94--67.7023.07
EV/FCF Ratio
22.0720.61--33.2920.43
Debt / Equity Ratio
0.420.420.510.780.820.84
Debt / EBITDA Ratio
3.122.6917.02-8.464.88
Debt / FCF Ratio
3.302.15--7.915.97
Net Debt / Equity Ratio
-0.17-0.23-0.25-0.19-0.20-0.16
Net Debt / EBITDA Ratio
-1.37-1.60-17.242.74-2.37-0.99
Net Debt / FCF Ratio
-1.31-1.1721.502.24-1.93-1.11
Asset Turnover
0.800.840.690.550.500.49
Inventory Turnover
0.770.750.630.510.500.87
Quick Ratio
2.311.972.963.283.904.69
Current Ratio
3.012.593.774.064.655.33
Return on Equity (ROE)
3.65%1.02%-5.38%-4.98%6.88%8.50%
Return on Assets (ROA)
3.47%4.55%-0.52%-3.06%1.57%3.68%
Return on Invested Capital (ROIC)
6.76%3.41%-2.10%-12.76%5.79%10.98%
Return on Capital Employed (ROCE)
6.80%8.50%-1.10%-5.70%2.80%6.80%
Earnings Yield
1.16%0.25%-1.82%-1.38%1.81%2.80%
FCF Yield
4.28%4.70%-0.40%-2.46%2.79%4.74%
Buyback Yield / Dilution
-12.83%-11.25%-2.18%7.09%-0.85%-2.70%